Inventor · disambiguated record
Stephen William Claridge
Also filed as: CLARIDGE STEPHEN · CLARIDGE STEPHEN W · CLARIDGE STEPHEN WILLIAM
20 granted patents·11 pending applications·35 citations·filing 2005–2024
92Inventor score
Top patents by PatentIndex Score
31 records- 0190US11365186B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2020·Granted Jun 21, 2022·3 cites·10 claims
- 0287US11981657B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 0385US10703740B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2016·Granted Jul 7, 2020·3 cites·13 claims
- 0483US8404846B2Inhibitors of protein tyrosine kinase activityCLARIDGE STEPHEN WILLIAM·Filed 2008·Granted Mar 26, 2013·8 cites·49 claims
- 0582US8907091B2Processes and intermediates for preparing fused heterocyclic kinase inhibitorsRAEPPEL FRANCK·Filed 2008·Granted Dec 9, 2014·7 cites·4 claims
- 0678US8455484B2Selected inhibitors of protein tyrosine kinase activityRAEPPEL STEPHANE·Filed 2011·Granted Jun 4, 2013·5 cites·15 claims
- 0778US7790729B2Inhibitors of VEGF receptor and HGF receptor signalingMETHYLGENE INC·Filed 2006·Granted Sep 7, 2010·1 cites·55 claims
- 0877US2024425481A1Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2024·Application pending·0 cites
- 0976US9018378B2Processes and intermediates for preparing fused heterocyclic kinase inhibitorsMETHYLGENE INC·Filed 2013·Granted Apr 28, 2015·1 cites·6 claims
- 1072US8093264B2Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signalingSAAVEDRA OSCAR MARIO·Filed 2006·Granted Jan 10, 2012·2 cites·25 claims
- 1171US7772247B2Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptorMETHYLGENE INC·Filed 2005·Granted Aug 10, 2010·1 cites·77 claims
- 1269US10501459B2Substituted imidazo[1,2-a]pyridines as bromodomain inhibitorsNEOMED INST·Filed 2016·Granted Dec 10, 2019·1 cites·27 claims
- 1367US8470850B2Inhibitors of VEGF receptor and HGF receptor signallingVAISBURG ARKADII·Filed 2010·Granted Jun 25, 2013·2 cites·46 claims
- 1460US2020299292A1Substituted [1,2,4]triazolo[4,3-a]pyridines, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2019·Application pending·0 cites
- 1558US8729268B2Inhibitors of protein tyrosine kinase activityMANNION MICHAEL·Filed 2009·Granted May 20, 2014·0 cites·20 claims
- 1656US2014315801A1Methods of treatment of cell proliferative and/or ophthalmic diseases, disorders and conditions using inhibitors of protein tyrosine kinase activityMETHYLGENE INC·Filed 2014·Application pending·0 cites
- 1755US2014179632A1Methods of inhibiting protein tyrosine kinase activityMETHYLGENE INC·Filed 2014·Application pending·0 cites
- 1854US8846927B2Inhibitors of protein tyrosine kinase activityMETHYLGENE INC·Filed 2013·Granted Sep 30, 2014·0 cites·20 claims
- 1952US8389541B2Inhibitors of protein tyrosine kinase activityCLARIDGE STEPHEN WILLIAM·Filed 2011·Granted Mar 5, 2013·0 cites·15 claims
- 2051US10519151B2Substituted [1,2,4]triazolo[4,3-A]pyridines, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2017·Granted Dec 31, 2019·0 cites·8 claims
- 2151US2020299291A1Substituted imidazopyridines, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2019·Application pending·0 cites
- 2249US8759522B2Inhibitors of protein tyrosine kinase activityMANNION MICHAEL·Filed 2010·Granted Jun 24, 2014·0 cites·10 claims
- 2347US2008064718A1Inhibitors of protein tyrosine kinase activitySAAVEDRA OSCAR M·Filed 2007·Application pending·0 cites
- 2443US8906852B2Inhibitors of protein tyrosine kinase activityRAEPPEL STÉPHANE·Filed 2011·Granted Dec 9, 2014·0 cites·17 claims
- 2541US8329726B2Inhibitors of VEGF receptor and HGF receptor signalingSAAVEDRA OSCAR MARIO·Filed 2011·Granted Dec 11, 2012·0 cites·13 claims
- 2641US2008255155A1Kinase inhibitors and uses thereofRAEPPEL STEPHANE·Filed 2007·Application pending·0 cites
- 2741US2010249145A1Inhibitors of VEGF Receptor and HGF Receptor SignalingMETHYLGENE INC·Filed 2010·Application pending·0 cites
- 2841US2013096136A1Inhibitors of Protein Tyrosine Kinase ActivityMETHYLGENE INC·Filed 2012·Application pending·0 cites
- 2940US2013096088A1Inhibitors of Protein Tyrosine Kinase ActivityMETHYLGENE INC·Filed 2012·Application pending·0 cites
- 3040US2008004273A1Inhibitors of protein tyrosine kinase activityRAEPPEL STEPHANE·Filed 2007·Application pending·0 cites
- 3136US10836742B2N-substituted bicyclic lactams, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2016·Granted Nov 17, 2020·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Stephen William Claridge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →